AbbVie (ABBV) FCF Payout Ratio (2013 - 2026)

AbbVie has disclosed FCF Payout Ratio across 14 years of filings, most recently posting 0.87 for Q1 2026.

• In Q1 2026, FCF Payout Ratio fell 58.56% year-over-year to 0.87; the TTM figure through Mar 2026 stood at 0.59 (down 18.59% YoY), while the FY2025 annual figure was 0.65, up 5.83% from the prior year.
• FCF Payout Ratio grew to 0.87 in Q1 2026, from 0.6 in the prior quarter.
• Over the last five years, FCF Payout Ratio for ABBV reached as high as 2.09 in Q1 2025 and fell as low as 0.34 in Q3 2022.
• The 5-year median for FCF Payout Ratio is 0.53 (2022), against an average of 0.67.
• Annual changes were most pronounced in 2024 — FCF Payout Ratio surged 216.92% — and 2026, when it plunged 58.56%.
• A 5-year view of FCF Payout Ratio shows it stood at 0.35 in 2022, then jumped by 66.24% to 0.58 in 2023, then dropped by 29.46% to 0.41 in 2024, then soared by 46.19% to 0.6 in 2025, then jumped by 45.42% to 0.87 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.87, 0.6, and 0.44 for Q1 2026, Q4 2025, and Q3 2025 respectively.